{"title":"Effect of pemirolast potassium on serum IL-4, IL-12 content in allergic rhinitis patients","authors":"R. Chai, K. Ning, Jing Liu, Hua Xie, Xiaoping Lin","doi":"10.3760/CMA.J.ISSN.1673-8799.2016.02.013","DOIUrl":null,"url":null,"abstract":"Objective \nTo study the influence of decoction cytokines in allergic rhinitis patients,and explore the therapeutic mechanism. \n \n \nMethods \n120 person wererandomized into 3 groups,40 allergic rhinitis (AR)group,40normal control group,40 Pemirolast potassium tablets group.The serum levels of IL-4 and IL-12 were determined by ELISA methods. \n \n \nResults \nPemirolast potassium serum level of IL-4 in Pemirolast potassium tablets decoction group significantly decreased compared with that of AR group (68.265±0.542) vs (38.547±1.065) (P<0.01),and the serum level of IL-12 in Pemirolast potassium tablets decoction group significantly increased (9.872±1.514) vs (15.245±1.598) (P<0.01).There is a positive correlation between them. \n \n \nConclusions \nThe therapeutic mechanism of Pemirolast potassium tablets decoction on allergic rhinitis is decreasing the level of IL-4 and increasing the level of IL-12, which suggests that IL-4 and IL-12 are important factors in the pathogenesis of AR. \n \n \nKey words: \nPemirolast potassium tablets; Allergic rhinitis; Interleukin","PeriodicalId":64135,"journal":{"name":"中国临床实用医学","volume":"7 1","pages":"47-49"},"PeriodicalIF":0.0000,"publicationDate":"2016-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国临床实用医学","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-8799.2016.02.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To study the influence of decoction cytokines in allergic rhinitis patients,and explore the therapeutic mechanism.
Methods
120 person wererandomized into 3 groups,40 allergic rhinitis (AR)group,40normal control group,40 Pemirolast potassium tablets group.The serum levels of IL-4 and IL-12 were determined by ELISA methods.
Results
Pemirolast potassium serum level of IL-4 in Pemirolast potassium tablets decoction group significantly decreased compared with that of AR group (68.265±0.542) vs (38.547±1.065) (P<0.01),and the serum level of IL-12 in Pemirolast potassium tablets decoction group significantly increased (9.872±1.514) vs (15.245±1.598) (P<0.01).There is a positive correlation between them.
Conclusions
The therapeutic mechanism of Pemirolast potassium tablets decoction on allergic rhinitis is decreasing the level of IL-4 and increasing the level of IL-12, which suggests that IL-4 and IL-12 are important factors in the pathogenesis of AR.
Key words:
Pemirolast potassium tablets; Allergic rhinitis; Interleukin